However, when utilizing the MR-Egger method, we observed a significant link between genetically predicted CRP levels and MPN risk, using both SNPs of genome-wide significance and those with a less strict threshold (p-values of 0.015 and 0.020, respectively,Fig. 2). Here, CRP is linked to myeloproliferative disorder.